| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.64B | 78.44B | 66.93B | 60.82B | 51.72B | 51.08B |
| Gross Profit | 28.17B | 49.20B | 44.02B | 41.00B | 34.82B | 33.58B |
| EBITDA | 32.44B | 33.70B | 29.48B | 27.61B | 22.63B | 21.98B |
| Net Income | 19.30B | 20.03B | 18.09B | 16.15B | 14.29B | 11.76B |
Balance Sheet | ||||||
| Total Assets | 84.26B | 93.50B | 83.31B | 78.58B | 70.48B | 70.96B |
| Cash, Cash Equivalents and Short-Term Investments | 36.79B | 50.86B | 37.70B | 36.45B | 34.30B | 34.89B |
| Total Debt | 3.71B | 4.25B | 5.18B | 5.96B | 6.60B | 8.26B |
| Total Liabilities | 23.65B | 31.37B | 31.62B | 30.42B | 22.31B | 23.82B |
| Stockholders Equity | 60.41B | 61.81B | 51.38B | 47.88B | 47.96B | 46.88B |
Cash Flow | ||||||
| Free Cash Flow | 22.79B | 26.79B | 19.25B | 22.04B | 15.65B | 16.67B |
| Operating Cash Flow | 23.33B | 27.49B | 19.53B | 22.59B | 16.03B | 17.29B |
| Investing Cash Flow | -11.36B | -3.02B | -2.23B | -2.87B | -1.31B | -2.18B |
| Financing Cash Flow | -18.16B | -11.30B | -16.08B | -17.57B | -15.31B | -9.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥390.89B | 22.87 | 32.41% | 3.62% | 20.98% | 0.48% | |
72 Outperform | ¥25.63B | 7.57 | 22.37% | 5.66% | -18.39% | ― | |
65 Neutral | ¥8.05B | 18.99 | ― | ― | 3.38% | 47.24% | |
63 Neutral | ¥49.51B | 58.36 | ― | ― | 22.37% | 655.34% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
41 Neutral | ¥3.52B | -15.74 | ― | ― | -3.79% | -272.95% | |
40 Underperform | ¥2.20B | 83.90 | ― | ― | 4.36% | ― |